The deal also aligns with Cencora’s broader mission of advancing specialty healthcare by leveraging the combined expertise of both organizations. The move is expected to bolster Cencora’s ...

Cencora, a global healthcare company, has expanded its Sure Supply Program to include 200 critical medications, including several oncology treatments, in response to ongoing drug shortages.

For the quarter ended December 2024, Cencora (COR) reported revenue of $81.49 billion, up 12.8% over the same period last year. EPS came in at $3.73, compared to $3.28 in the year-ago quarter.